Feedback / Questions
infliximab oral (TH023) - Celltrion, Tharimmune, Intract Pharma
https://www.accessnewswire.com/newsroom/en/biotechnology/tharimmune-announces-positive-results-for-novel-oral-monoclonal-antibody-th023-target-1004175
Mar 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next